90760-96-6 Usage
Uses
Used in Pharmaceutical Industry:
(Des-Gly10,His(Bzl)6,Pro-NHEt9)-LHRH is used as a therapeutic agent for hormone-dependent diseases such as prostate cancer and endometriosis. (Des-Gly10,His(Bzl)6,Pro-NHEt9)-LHRH's ability to modulate reproductive functions makes it a valuable tool in the development of treatments for these conditions.
Used in Research Applications:
In the field of research, (Des-Gly10,His(Bzl)6,Pro-NHEt9)-LHRH serves as a valuable compound for studying the effects of LHRH on reproductive functions and hormone regulation. Its modified structure allows for a deeper understanding of the mechanisms involved in hormone-dependent diseases and the potential for developing targeted therapies.
Used in Drug Design and Development:
(Des-Gly10,His(Bzl)6,Pro-NHEt9)-LHRH is utilized in the design and development of new therapeutic agents for hormone-dependent diseases. Its unique structure and function provide insights into the interactions between hormones and their receptors, which can be leveraged to create more effective and targeted treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 90760-96-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,7,6 and 0 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 90760-96:
(7*9)+(6*0)+(5*7)+(4*6)+(3*0)+(2*9)+(1*6)=146
146 % 10 = 6
So 90760-96-6 is a valid CAS Registry Number.
90760-96-6Relevant academic research and scientific papers
Bioerodible device for administering active ingredients
-
, (2008/06/13)
The invention relates to a muco-adherent, soluble device for administering active ingredients, a method of using said device, and an improved method of manufacturing said device using a continuous, enclosed mixing device capable of operating under pressure. The devices of the invention, which comprise a lyophilized foam and an active ingredient, have a dissolution time of at least about 8 hours, and preferably at least about 24 hours, and can provide for the sustained and/or controlled release of an active ingredient for up to about 24 hours.
